Around 20 percent of Janssen's global clinical trials have Nordic sites, with approximately 40 ongoing studies in Sweden
In Conversation
Sweden is sitting on a wealth of health data contained in its national quality registries which provide a unique source of real-world evidence. We act as…
Europe, in general, is a tough market, and among European countries, the UK and the Nordics are the most challenging in terms of HTA and market…
With Mangoral, we are exclusively targeting patients with poor kidney functions that are not eligible for currently available products. That is an open space where there…
The creation of Chiesi Nordics in 2014 marked the dawn of a new era for the group in the region
BioGaia never launches a product that has not been clinically tested.
Historically, Sweden has been an early adopter of orphan drugs. In terms of market access, what sets Sweden apart is its value-based system of approval and…
At Bluefish we believe that price competitiveness is not the only key success factor in the generics business
Research shows that investing in primary care is the best way to achieve a more inclusive healthcare system.
My mission as CEO was to transform the structure of Medivir to a company laser-focused on clinical development and business development
Even the President of the United States of America has called the opioid crisis a public health emergency and made it a high priority. Orexo is…
We are used to collaborating closely together because we are a relatively small country, so we have to be practical in our approach
